human-icon-transDiagnovus is a personalized information company focused on fundamentally changing the way patients are treated. We provide clinically actionable genomic information about a patient’s individual disease, aiding physicians and health care professionals in making vital decisions. With more precise information, doctors will be able to choose or modify the appropriate therapeutic regimens, leading to better outcomes for their patients.

LEARN MORE ABOUT US…

April 18, 2014
Diagnovus to Develop First Genetic Test for Patients with Eosinophilic Esophagitis. ENGAUGE® GI EoE assay licensed from Cincinnati Children’s improves diagnosis and treatment. NASHVILLE, Tenn.…

Read more

January 29, 2014
We would like to congratulate our president, Dr. James Stover, on winning the Nashville Business Journal’s ‘2014 40 Under 40 Award’! This award goes to those…

Read more

January 17, 2014
If you want to talk to us more in person about our what we do to help doctors and patients fight rare, orphan and less…

Read more

engauge-your-disease

DLBCL

Diffuse Large B-cell
Lymphoma

CLL

Chronic Lymphocytic
Leukemia

MYE

Myeloid Disease

MCL

Mantle Cell Lymphoma

t-ALL

T-cell Acute
Lymphoblastic Leukemia

BE

Barrett’s
Esophagus

EoE

Eosinophilic
Esophagitis


Call us at (855) 642-9438 to learn more…

We strive to make a meaningful contribution to improving outcomes for patients and helping physicians provide more effective care.
Learn how we can do this for you by contacting us today.